• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Comparison of echocardiographic findings in patients with aldosterone-producing adenomas: adrenalectomy versus mineralocorticoid receptor antagonists.

作者信息

Haze Tatsuya

机构信息

Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.

Department of Nephrology and Hypertension, Yokohama City University Medical Center, Yokohama, Japan.

出版信息

Hypertens Res. 2025 Feb;48(2):816-818. doi: 10.1038/s41440-024-02008-8. Epub 2024 Nov 28.

DOI:10.1038/s41440-024-02008-8
PMID:39609647
Abstract
摘要

相似文献

1
Comparison of echocardiographic findings in patients with aldosterone-producing adenomas: adrenalectomy versus mineralocorticoid receptor antagonists.原发性醛固酮增多症腺瘤患者超声心动图检查结果的比较：肾上腺切除术与盐皮质激素受体拮抗剂治疗对比
Hypertens Res. 2025 Feb;48(2):816-818. doi: 10.1038/s41440-024-02008-8. Epub 2024 Nov 28.
2
Evaluating the effects of adrenalectomy and mineralocorticoid receptor antagonist on cardiac remodeling and diastolic function in patients with aldosterone-producing adenoma.评估肾上腺切除术和盐皮质激素受体拮抗剂对原发性醛固酮增多症患者心脏重塑和舒张功能的影响。
Hypertens Res. 2025 Feb;48(2):529-539. doi: 10.1038/s41440-024-01946-7. Epub 2024 Oct 25.
3
Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.醛固酮受体拮抗剂对原发性醛固酮增多症患者醛固酮/肾素比值的影响。
J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3655-e3664. doi: 10.1210/clinem/dgab290.
4
Risk of new-onset diabetes mellitus in primary aldosteronism: a population study over 5 years.原发性醛固酮增多症患者新发糖尿病的风险：一项为期5年的人群研究
J Hypertens. 2017 Aug;35(8):1698-1708. doi: 10.1097/HJH.0000000000001361.
5
[Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].基于187例原发性醛固酮增多症的回顾性分析的诊断与治疗结果
Orv Hetil. 2006 Jan 15;147(2):51-9.
6
[Hyperaldosteronism].[醛固酮增多症]
Internist (Berl). 2021 Mar;62(3):245-251. doi: 10.1007/s00108-021-00972-8. Epub 2021 Feb 18.
7
Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism.肾上腺切除术或盐皮质激素拮抗剂对原发性醛固酮增多症患者的长期心脏影响。
Hypertension. 2007 Nov;50(5):911-8. doi: 10.1161/HYPERTENSIONAHA.107.095448. Epub 2007 Sep 24.
8
High rate of detection of primary aldosteronism, including surgically treatable forms, after 'non-selective' screening of hypertensive patients.对高血压患者进行“非选择性”筛查后，原发性醛固酮增多症（包括可手术治疗的类型）的检出率很高。
J Hypertens. 2003 Nov;21(11):2149-57. doi: 10.1097/00004872-200311000-00025.
9
Mineralocorticoid Receptor Antagonists in Primary Aldosteronism.醛固酮受体拮抗剂在原发性醛固酮增多症中的应用。
Curr Pharm Des. 2018;24(46):5508-5516. doi: 10.2174/1381612825666190311130138.
10
Hemodynamic and Non-Hemodynamic Components of Cardiac Remodeling in Primary Aldosteronism.原发性醛固酮增多症中心脏重构的血液动力学和非血液动力学成分。
Front Endocrinol (Lausanne). 2021 Apr 19;12:646097. doi: 10.3389/fendo.2021.646097. eCollection 2021.

本文引用的文献

1
Recent progress in unraveling cardiovascular complications associated with primary aldosteronism: a succinct review.原发性醛固酮增多症相关心血管并发症研究的最新进展：简要综述
Hypertens Res. 2024 May;47(5):1103-1119. doi: 10.1038/s41440-023-01538-x. Epub 2024 Jan 16.
2
Effect of the interaction between the visceral-to-subcutaneous fat ratio and aldosterone on cardiac function in patients with primary aldosteronism.原发性醛固酮增多症患者内脏脂肪与皮下脂肪比值与醛固酮相互作用对心功能的影响。
Hypertens Res. 2023 May;46(5):1132-1144. doi: 10.1038/s41440-023-01170-9. Epub 2023 Feb 8.
3
Japan Endocrine Society clinical practice guideline for the diagnosis and management of primary aldosteronism 2021.
日本内分泌学会2021年原发性醛固酮增多症诊断与管理临床实践指南
Endocr J. 2022 Apr 28;69(4):327-359. doi: 10.1507/endocrj.EJ21-0508. Epub 2022 Apr 12.
4
Persistent cardiac organ damage in surgically and medically treated primary aldosteronism.原发性醛固酮增多症手术和药物治疗后持续的心脏器官损害。
J Hypertens. 2022 Jun 1;40(6):1204-1211. doi: 10.1097/HJH.0000000000003135. Epub 2022 Mar 11.
5
Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.原发性醛固酮增多症治疗后血压达标与长期肾功能的关系。
J Hum Hypertens. 2022 Oct;36(10):904-910. doi: 10.1038/s41371-021-00595-4. Epub 2021 Aug 30.
6
Association of the ratio of visceral-to-subcutaneous fat volume with renal function among patients with primary aldosteronism.原发性醛固酮增多症患者内脏脂肪与皮下脂肪体积比与肾功能的关系。
Hypertens Res. 2021 Oct;44(10):1341-1351. doi: 10.1038/s41440-021-00719-w. Epub 2021 Aug 6.
7
Association of aldosterone and blood pressure with the risk for cardiovascular events after treatments in primary aldosteronism.醛固酮和血压与原发性醛固酮增多症治疗后心血管事件风险的关系。
Atherosclerosis. 2021 May;324:84-90. doi: 10.1016/j.atherosclerosis.2021.03.033. Epub 2021 Mar 29.
8
Regression of left ventricular hypertrophy in primary aldosteronism after adrenalectomy: a meta-analysis of echocardiographic studies.醛固酮增多症患者肾上腺切除术后左心室肥厚的消退：超声心动图研究的荟萃分析。
J Hypertens. 2021 Apr 1;39(4):775-783. doi: 10.1097/HJH.0000000000002679.
9
Associations Between Changes in Plasma Renin Activity and Aldosterone Concentrations and Changes in Kidney Function After Treatment for Primary Aldosteronism.原发性醛固酮增多症治疗后血浆肾素活性和醛固酮浓度变化与肾功能变化之间的关联
Kidney Int Rep. 2020 Jun 20;5(8):1291-1297. doi: 10.1016/j.ekir.2020.06.012. eCollection 2020 Aug.
10
Left Ventricular Dysfunction in Patients With Primary Aldosteronism: A Propensity Score-Matching Follow-Up Study With Tissue Doppler Imaging.原发性醛固酮增多症患者的左心室功能障碍：应用组织多普勒成像的倾向评分匹配随访研究。
J Am Heart Assoc. 2019 Nov 19;8(22):e013263. doi: 10.1161/JAHA.119.013263. Epub 2019 Nov 13.